Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...
Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...
Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback